BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11067844)

  • 1. A bipartite substrate recognition motif for cyclin-dependent kinases.
    Takeda DY; Wohlschlegel JA; Dutta A
    J Biol Chem; 2001 Jan; 276(3):1993-7. PubMed ID: 11067844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism.
    Clare PM; Poorman RA; Kelley LC; Watenpaugh KD; Bannow CA; Leach KL
    J Biol Chem; 2001 Dec; 276(51):48292-9. PubMed ID: 11604388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
    Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
    Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
    Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
    Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of CDK2-cyclin A. What is optimal?
    Stevenson-Lindert LM; Fowler P; Lew J
    J Biol Chem; 2003 Dec; 278(51):50956-60. PubMed ID: 14506259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state.
    Bogdanow B; Weisbach H; von Einem J; Straschewski S; Voigt S; Winkler M; Hagemeier C; Wiebusch L
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17510-5. PubMed ID: 24101496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK phosphorylation inhibits the DNA-binding and ATP-hydrolysis activities of the Drosophila origin recognition complex.
    Remus D; Blanchette M; Rio DC; Botchan MR
    J Biol Chem; 2005 Dec; 280(48):39740-51. PubMed ID: 16188887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A.
    Zheleva DI; McInnes C; Gavine AL; Zhelev NZ; Fischer PM; Lane DP
    J Pept Res; 2002 Nov; 60(5):257-70. PubMed ID: 12383116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
    EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of cyclin A and cyclin kinase inhibitor p21 in response to gamma-irradiation requires the CDK2 binding region, but not the Cy motif.
    Fukuchi K; Nakamura K; Ichimura S; Tatsumi K; Gomi K
    Biochim Biophys Acta; 2003 Oct; 1642(3):163-71. PubMed ID: 14572899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal helix of Xenopus cyclins A and B contributes to binding specificity of the cyclin-CDK complex.
    Goda T; Funakoshi M; Suhara H; Nishimoto T; Kobayashi H
    J Biol Chem; 2001 May; 276(18):15415-22. PubMed ID: 11278837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.